The stock of 60 Degrees Pharmaceuticals Inc (SXTP) has gone up by 25.22% for the week, with a 21.52% rise in the past month and a 77.78% rise in the past quarter. The volatility ratio for the week is 7.56%, and the volatility levels for the past 30 days are 7.54% for SXTP. . The simple moving average for the past 20 days is 18.92% for SXTP’s stock, with a -34.38% simple moving average for the past 200 days.
Is It Worth Investing in 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Right Now?
Company’s 36-month beta value is 2.87.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SXTP is 1.38M, and currently, short sellers hold a 2.36% ratio of that floaft. The average trading volume of SXTP on June 04, 2025 was 1.52M shares.
SXTP) stock’s latest price update
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) has experienced a decline in its stock price by -1.03 compared to its previous closing price of 2.91. However, the company has seen a gain of 25.22% in its stock price over the last five trading days. globenewswire.com reported 2025-06-04 that New 8-count bottles now available through major retail pharmacies ARAKODA® is the only weekly prophylactic therapy to provide protection against the blood and liver stages of malaria WASHINGTON, June 04, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the introduction of a new 8-count bottle format for ARAKODA® (tafenoquine). The 8-count bottle format may be suitable for use with patients who are making shorter trips to areas of the world where malaria is endemic.
SXTP Trading at 16.45% from the 50-Day Moving Average
After a stumble in the market that brought SXTP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.00% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at SXTP starting from XU CHERYL, who purchase 6,000 shares at the price of $1.56 back on Dec 13 ’24. After this action, XU CHERYL now owns 52,078 shares of 60 Degrees Pharmaceuticals Inc, valued at $9,375 using the latest closing price.
XU CHERYL, the Director of 60 Degrees Pharmaceuticals Inc, purchase 5,000 shares at $1.82 during a trade that took place back on Dec 12 ’24, which means that XU CHERYL is holding 46,078 shares at $9,125 based on the most recent closing price.
Stock Fundamentals for SXTP
Current profitability levels for the company are sitting at:
- -15.71 for the present operating margin
- 0.4 for the gross margin
The net margin for 60 Degrees Pharmaceuticals Inc stands at -15.65. The total capital return value is set at -2.47. Equity return is now at value -181.43, with -142.93 for asset returns.
Currently, EBITDA for the company is -7.88 million with net debt to EBITDA at 0.34. When we switch over and look at the enterprise to sales, we see a ratio of 1.14. The receivables turnover for the company is 1.34for trailing twelve months and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.13.
Conclusion
In a nutshell, 60 Degrees Pharmaceuticals Inc (SXTP) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
